Chemo boosts cancer survival in older women

Posted Dec 12, 2009 by Gordon K. Chan
A new study shows the combination of chemotherapy with standard tamoxifen treatment improves cancer survival of older women.
rev bri / flickr
A study which involved 1,500 post menopausal women in a 10-year study revealed "landmark" findings, reports MSNBC. It has been revealed by U.S. researchers that adding chemotherapy to tamoxifen in the treatment of estrogen-receptor positive breast cancers significantly improves disease free survival.
Specifically, the advantages are observed when tamoxifen follows chemotherapy.
Tamoxifin has been a standard treatment for early and advanced breast cancer in pre- and post-menopausal women.
Dr. Kathy Albain of Loyola University Health System, who presented findings of the study, states: "We have a survival benefit that lasts for a very long time ... for women who got both modalities of treatment versus women who just go tamoxifen."
A large clinical trial will begin to further examine the effectiveness of the treatment.